IL-4 levels of CD19+ B cells showed significant decreases in ZAP70- CLL patients compared to healthy subjects (p<0.004), whereas IL-4 levels between ZAP70+ and ZAP70- patients did not show any difference. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.